NITO
Nexentis Technologies Inc.
Key Financials
Gross Profit
$45000
↓ 78.4%
Revenue
$210000
↓ 20.3%
Net Income
$-4004000
↑ 22.9%
Operating Income
$-4230000
↑ 2.1%
Total Assets
$20.4M
↑ 273.4%
EPS (Diluted)
$-8.61
↓ 867.4%
Total Liabilities
$4.7M
↑ 424.1%
Shareholders' Equity
$16.0M
↑ 237.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/6/2026 | View on SEC |
| PRE 14A | 10/5/2026 | View on SEC |
| 8-K | 9/3/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| EFFECT | 7/17/2026 | View on SEC |
| EFFECT | 7/15/2026 | View on SEC |
| SCHEDULE 13G/A | 7/15/2026 | View on SEC |
| S-1 | 7/13/2026 | View on SEC |
| POS AM | 7/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NITO |
| Company Name | Nexentis Technologies Inc. |
| CIK | 1789192 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 972544561349 |